narcolepsy

Sleep disorder insomnia
Biotech

Lilly pays $6.3B upfront for sleep disorder-focused Centessa

Eli Lilly has gone big in the name of neuroscience, paying $6.3 billion in a front-loaded deal for Centessa and its sleep disorder pipeline.
James Waldron Mar 31, 2026 8:53am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Alkermes races to phase 3 after posting another narcolepsy win

Nov 12, 2025 9:30am
Takeda

Takeda drops AZ-partnered neurological program after ph. 2 fail

Oct 30, 2025 9:25am
Close up of horse legs and hooves running on sand track

Takeda, Alkermes lift lid on narcolepsy rivals as race heats up

Sep 8, 2025 6:47am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Chasing Takeda, Alkermes reports phase 2 narcolepsy win

Jul 21, 2025 8:40am
Arrows hitting targets

Takeda narcolepsy blockbuster hopeful secures double ph. 3 wins

Jul 14, 2025 5:51am